RT @freddyeescorcia@twitter.com

Lots of folks in #nucmed and #radonc are interested in launching their own #radiopharmaceuticals ☢️therapy program, but not sure where to start.

If you're in this camp, you're in luck!🍀

@jmmrad@twitter.com and the team @WashURadOnc@twitter.com put together this comprehensive guide!

👇👇👇

🐦🔗: https://twitter.com/freddyeescorcia/status/1619770317756592132

Lots of folks in #nucmed and #radonc are interested in launching their own #radiopharmaceuticals ☢️therapy program, but not sure where to start.

If you're in this camp, you're in luck!🍀

@jmmrad@twitter.com and the team @WashURadOnc@twitter.com put together this comprehensive guide!

👇👇👇

Friday afternoon resubmission ftw!

#RadOnc #Oncology #NucMed #LiverCancer

Major revisions that are really minor and don’t require new experiments. Yes please and thank you!

Nice way to start off the weekend!

Proud of my team!

#academia #radonc #oncodon #oncology #nucmed

Thanks for the kind words @OncoThor@twitter.com!

Trying to make #radiopharmaceuticals accessible to physicians to make them available for patients.

Grateful to @KilianSalerno@twitter.com @SouMyajiT_RO@twitter.com @RPatelMDPHD@twitter.com and coauthors, @ASTRO_org@twitter.com @IJROBP@twitter.com and @sueyom@twitter.com for the opportunity to publish our Primer!

#RadOnc #NucMed #Oncology #Oncodon @sueyom

@Kmachel

Did you see this yet?

https://aacrjournals.org/clincancerres/article/doi/10.1158/1078-0432.CCR-22-1931/711352/Gallium-68-labeled-Peptide-PET-Quantifies-Tumor

#nucmed #radonc #oncodon #oncology

TFW you submitted a grant review!

#radonc #nucmed #MedMastodon #academia #medtwitter #academictwitter

1/2

Excited to be launching this trial!

#livertwitter #livercancer #nucmed #radiopharmaceuticals

RT @PLOSONE@twitter.com

New #StudyProtocol from @freddyeescorcia@twitter.com and colleagues at @NCICCR_MIP@twitter.com: Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma

https://doi.org/10.1371/journal.pone.0277407

🐦🔗: https://twitter.com/PLOSONE/status/1598315990424633345

Can anyone help me understand the continued #radiopharmaceuticals work with girentuximab given that a phase 2 published in 2016 was underwhelming? 🤔🤷🏽‍♂️

I’m surely missing something.

#oncology #nucmed #radonc

https://www.sciencedirect.com/science/article/pii/S030228381501204X

@Kmachel

Nice! This recent paper in JACS might be of interest then: https://pubs.acs.org/doi/full/10.1021/jacs.2c08438

#oncology #radiopharmaceuticals #radonc #nucmed

#NET peeps might find the work of interest
@marklewismd@twitter.com @samira_sadowski@twitter.com @PamelaKunzMD@twitter.com @OncoThor@twitter.com @AmanChauhanMD@twitter.com @RPatelMDPHD@twitter.com @JaydiDelRivero@twitter.com @gwiezdzinska@twitter.com @NANETS1@twitter.com @CureNETs@twitter.com

#radonc #nucmed #radiopharmaceuticals #NETresearch

11/

Lu-dotatate changed how patients with SSTR+ NETs are treated.

Still, many patients have NETs that don’t respond or develop resistance to Lu-dotatate
#radiopharmaceuticals therapy.

Could alpha particle therapy help?

🧵 1/

@CureNETs@twitter.com @NANETS1@twitter.com #nucmed #radonc #oncology

Hello former #medtwitter and now #medmastodon

I am a trained ☢️ #radiochemist 🧪 who wants to stay on top of ☢️ #nucmed 💉🩺

So anybody who works with #PET #SPECT #PRRT #TRT or and especially #TAT feel free to reach out and discuss 💪☺️

So I am very excited to be part of a new #nuclearmedicine network here 🤗

Hi #medmastodon! Hoping that the #radiology community finds a place over here. I’m an Australian #radiologist & #nucmed who enjoys teaching, writing & starting conversations #meded #radiopaedia

Hi #medmastodon! Hoping that the #radiology community finds a place over here. I’m an Australian #radiologist & #nucmed who enjoys teaching, writing & starting conversations #meded #radiopaedia

@freddyeescorcia nice a fellow #nucmed ! 🤗

What are you working on? Standard care or novel compounds?

#introductions

Hi Mastodonians!

I am an oncologist and scientist at the NCI developing #radiopharmaceuticals in the lab to help image and treat human cancers.

My research sits at the interface of #oncology #chemistry #radiochemistry #drugdevelopment #clinicaltrials #nucmed #radonc.

Beyond the professional, I enjoy #audiobooks, #fitness, #coffee, and occasional #beer #homebrewing.

Looking to connect with and learn from diverse thinkers in oncology, medicine, and beyond.

RT @freddyeescorcia
Proud of @NIHOxCam PhD student Stan Fayn for submitting his first first author paper along phenom postdoc Paden King.

✅nanobody
✅site-specific conjugation
✅immunoPET
✅liver cancer

And now, the waiting game...

#radonc #nucmed @IRPatNIH @NCIResearchCtr @NCICCR_MIP @theNCI